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Abstract
Background: The release of tumor necrosis factor-a (TNF-a) appears depend on the P2X7 receptor, a purinergic
receptor. In the present study, we addressed the question of whether P2X7 receptor-mediated TNF-a regulation is
involved in pathogenesis and outcome of status epilepticus (SE).
Methods: SE was induced by pilocarpine in rats that were intracerebroventricularly infused with saline-, 2’,3’-O-
(4-benzoylbenzoyl)-adenosine 5’-triphosphate (BzATP), adenosine 5’-triphosphate-2’,3’-dialdehyde (OxATP), A-438079,
or A-740003 prior to SE induction. Thereafter, we performed Fluoro-Jade B staining and immunohistochemical
studies for TNF-a and NF-B subunit phosphorylations.
Results: Following SE, P2X7 receptor agonist (BzATP) infusion increased TNF-a immunoreactivity in dentate granule
cells as compared with that in saline-infused animals. In addition, TNF-a immunoreactivity was readily apparent in
the mossy fibers, while TNF-a immunoreactivity in CA1-3 pyramidal cells was unaltered. However, P2X7 receptor
antagonist (OxATP-, A-438079, and A-740003) infusion reduced SE-induced TNF-a expression in dentate granule
cells. In the CA3 region, BzATP infusion attenuated SE-induced neuronal damage, accompanied by enhancement of
p65-Ser276 and p65-Ser311 NF-B subunit phosphorylations. In contrast, OxATP-, A-438079, and A-740003 infusions
increased SE-induced neuronal death. Soluble TNF p55 receptor (sTNFp55R), and cotreatment with BzATP and
sTNFp55R infusion also increased SE-induced neuronal damage in CA3 region. However, OxATP-, sTNFp55R or
BzATP+sTNFp55R infusions could not exacerbate SE-induced neuronal damages in the dentate gyrus and the CA1
region, as compared to BzATP infusion.
Conclusions: These findings suggest that TNF-a induction by P2X7 receptor activation may ameliorate SE-induced
CA3 neuronal damage via enhancing NF-B p65-Ser276 and p65-Ser311 phosphorylations.
Background
Status epilepticus (SE) is a medical emergency with sig-
nificant mortality [1]. SE has been defined as continuous
seizure activity, which causes neuronal cell death [2,3],
epileptogenesis [3] and learning impairment [4]. Cyto-
kines are critical mediators of specific inflammatory
responses and immune reactions in the brain [5].
Tumor necrosis factor-a (TNF-a) is a 17-kDa protein
that is mainly produced by activated macrophages and
T cells of the immune system. TNF-a is expressed at
low levels in the normal brain and is rapidly upregulated
in glia, neurons and endothelial cells in various patho-
physiological conditions [6]. TNF-a shows various
effects on brain function depending on its local tissue
concentration, the type of target cells, and especially the
specific receptor subtype: TNF receptor I, or p55 recep-
tor (TNFp55R); and TNF receptor II, or p75 receptor
(TNFp75R) [7,8]. Basically, TNF-related signal transduc-
tion pathways involve NF-B binding activity for
TNFp55R contributing to cell death [9] and downstream
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gen-activated protein kinase to promote neuronal survi-
val [10]. However, TNFp55R deficiency enhances
KA-induced excitotoxic hippocampal injury in mice
[11]. Furthermore, Marchetti et al. [12] has reported
that TNFp75R-induced persistent NF-B activity is
essential for neuronal survival against excitotoxic stress.
Therefore, TNF-a c l e a r l yp o s s e s s e st h ea b i l i t yt os i m u l -
taneously activate both cell death and cell survival path-
ways, and this balance ultimately determines whether
TNF-a promotes neurodegeneration or neuroprotection.
On the other hand, P2X7 receptor, a purinergic recep-
tor, plays a role in intercellular signaling involving ATP
and glutamate release. Furthermore, the release of TNF-
a appears to be dependent on the P2X7 receptor.
Indeed, treatment of microglia in neuron-microglia co-
cultures with the P2X7 agonist 2’-3’-O-(benzoyl-benzoyl)
ATP (BzATP) leads to significant reductions in gluta-
mate-induced neuronal cell death, and either TNF-a
converting enzyme inhibitor or anti-TNF-a IgG readily
suppresses this protective effect [13]. In contrast, Choi
et al. [14] have reported that the P2X7 receptor antago-
nist, oxidized ATP (OxATP), is effective in attenuating
LPS-induced neuronal damage. These findings encour-
aged us to speculate that P2X7 receptor-mediated TNF-
a regulation is involved in outcomes of SE. In the pre-
sent study, therefore, we address the question of
whether the effects of P2X7 receptor on the TNF-a sys-
tem represent general features of SE-induced neuronal
death in the hippocampus following SE.
Methods
Experimental animals and chemicals
This study utilized the progeny of Sprague-Dawley (SD)
rats (male, 9-11 weeks old) obtained from Experimental
Animal Center, Hallym University, Chunchon, South
Korea. The animals were provided with a commercial
diet and water ad libitum under controlled temperature,
humidity and lighting conditions (22 ± 2°C 55 ± 5% and
a 12:12 light/dark cycle with lights). Procedures involving
animals and their care were conducted in accord with
our institutional guidelines that comply with NIH Guide
for the Care and Use of Laboratory Animals (NIH Publi-
cations No. 80-23, 1996). In addition, we have made all
efforts to minimize the number of animals used and their
suffering. All reagents were obtained from Sigma-Aldrich
(St. Louis, MO), except as noted.
Intracerebroventricular drug infusion
Rats were divided into eight groups, treated with either (1)
saline, (2) vehicle (0.1% DMSO/saline, v/v), (3) BzATP (5
mM in saline), (4) OxATP (5 mM in saline), (5) A-438079
(10 μM in saline; Tocris Bioscience, Ellis-ville, MO), (6) A-
740003 (10 μM in 0.001% DMSO/saline, v/v; Tocris
Bioscience, Ellis-ville, MO), (7) soluble TNFp55R
(sTNFp55R 50 μg/ml), or (8) BzATP (5 mM) + sTNFp55R
(50 μg/ml). The dosage of each compound was deter-
mined as the highest dose that did not affect seizure
threshold in a preliminary study. Animals were anesthe-
tized (Zolretil, 50 mg/kg, i.m.; Virbac Laboratories) and
placed in a stereotaxic frame. For osmotic pump implanta-
tion, holes were drilled through the skull to introduce a
brain infusion kit 1 (Alzet, Cupertino, CA) into the right
lateral ventricle (1 mm posterior; 1.5 mm lateral;–3.5 mm
depth; flat skull position with bregma as reference),
according to the atlas of Paxinos and Watson [15]. The
infusion kit was sealed with dental cement and connected
to an osmotic pump (1002, Alzet, Cupertino, CA). The
pump was placed in a subcutaneous pocket in the dorsal
region. Animals received 0.5 μl/hr of vehicle or compound
for 2 weeks [16-18].
Seizure induction
Three days after the start of vehicle or compound infu-
sion, rats were treated with pilocarpine (380 mg/kg, i.p.)
20 min after methylscopolamine (5 mg/kg, i.p.).
Approximately 80% of pilocarpine-treated rats showed
acute behavioral features of status epilepticus (SE),
including akinesia, facial automatisms, limbic seizures
consisting of forelimb clonus with rearing, salivation,
masticatory jaw movements, and falling. Diazepam
(Valium, 10 mg/kg, i.p.; Hoffman Ia Roche, Neuilly sur-
Seine) was administered 2 hours after onset of SE and
repeated, as needed. The rats were then observed 3-4
hours a day in a vivarium for general behavior and
occurrence of spontaneous seizures. Non-experienced
SE rats (which showed only acute seizure behaviors dur-
ing 10-30 min, n = 21) and age-matched normal rat
were used as controls (n = 8).
Pilocarpine-induced seizure threshold
Three days after the start of vehicle or compound infu-
sion, some animals (n = 3) in each group were anesthe-
tized (urethane, 1.5 g/kg, i.p.) and placed in a
stereotaxic frame. Holes were drilled through the skull
to introduce electrodes. The coordinates (in mm) were
as follows. For the recording electrode (to the dentate
gyrus):-3.8 anterior-posterior, 2.5 lateral to bregma, 2.9
depth, at a right angle to the skull surface. For the sti-
mulating electrode (to the angular bundle): 4.2 lateral to
lambda, 3.0 depth. Stainless steel electrodes (Plastics
One Inc) were used for recording. Reference electrodes
were placed in the posterior cranium over the cerebel-
lum. Signals were recorded with DAM 80 differential
amplifier (0.1-3000 Hz bandpass, World Precision
Instruments) and data were digitized (20 kHz) and ana-
lyzed on MacChart 5 (AD Instruments). After establish-
ing a stable baseline for at least 30 min after surgery,
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methylscopolamine (5 mg/kg, i.p.), and latency was
observed. Latency was determined as seconds from the
pilocarpine injection time point to the time point show-
ing the first seizure activity [19]. To analyze changes in
EEG power value, root mean square (RMS) values were
also measured.
Tissue processing
At designated time points (Non-SE, 1 day, 2 days, 3 days
and 1 week after SE, n = 5, respectively), animals were
perfused transcardially with phosphate-buffered saline
(PBS) followed by 4% paraformaldehyde in 0.1 M phos-
phate buffer (PB, pH 7.4) under urethane anesthesia (1.5
g/kg, i.p.). The brains were removed, and postfixed in
the same fixative for 4 hr. The brain tissues were cryo-
protected by infiltration with 30% sucrose overnight.
Thereafter, the entire hippocampus was frozen and sec-
tioned with a cryostat at 30 μm and consecutive sections
were placed in six-well plates containing PBS. For
stereological study, every sixth section in the series
throughout the entire hippocampus was used in some
animals [20].
Immunohistochemistry
Sections were first incubated with 3% bovine serum
albumin in PBS for 30 min at room temperature. Sec-
tions were then incubated in primary antibody (Table 1)
in PBS containing 0.3% Triton X-100 overnight at room
temperature. The sections were washed three times for
10 min with PBS, incubated sequentially, in biotinylated
horse anti-mouse IgG (Vector, Burlingame, CA) and
ABC complex (Vector, Burlingame, CA), diluted 1:200
in the same solution as the primary antiserum. Between
incubations, the tissues were washed with PBS three
times for 10 min each. The sections were visualized
with 3,3’-diaminobenzidine (DAB) in 0.1 M Tris buffer
and mounted on gelatin-coated slides. The immunoreac-
tions were observed under an Axiophot microscope
(Carl Zeiss, Munchen-Hallbergmoos). All images were
captured using an Axiocam HRc camera and Axio
Vision 3.1 software [21-23]. To identify the morphologi-
cal changes induced by SE in the same hippocampal tis-
sue, double immunofluorescent staining was also
performed. Brain tissues were incubated in a mixture of
goat anti-TNF-a IgG/mouse anti-calbindin D-28 k IgG
(a granule cell marker) or mouse anti-GFAP IgG (an
astroglial marker)/rabbit anti-TNFp55R IgG or mouse
anti-GFAP IgG/TNFp75R IgG in PBS containing 0.3%
triton X-100 overnight at room temperature. After
washing three times for 10 minutes with PBS, sections
were also incubated in a mixture of FITC-or Cy3-conju-
gated secondary antisera (Amersham, San Francisco,
C A )f o r1h ra tr o o mt e m p e r a t u r e .S e c t i o n sw e r e
mounted in Vectashield mounting media with or with-
out DAPI (Vector, Burlingame, CA). For negative con-
trols, rat hippocampal tissues were incubated with only
the secondary antibody without primary antibody. All
negative controls for immunohistochemistry resulted in
the absence of immunoreactivity in any structure (data
not shown).
Fluoro-Jade B staining
Fluoro-Jade B (FJB) staining was used to identify degen-
erating neurons. Briefly, sections were rinsed in distilled
water, and mounted onto gelatin-coated slides and then
dried on a slide warmer. The slides were immersed in
100% ethanol for 3 min, followed by 70% ethanol for
2 min and distilled water for 2 min. The slides were
then transferred to 0.06% potassium permanganate for
15 min and gently agitated. After rinsing in distilled
water for 2 min, the slides were incubated for 30 min in
0.001% FJB (Histo-Chem Inc. Jefferson, AR), freshly pre-
pared by adding 20 ml of a 0.01% stock FJB solution to
180 ml of 0.1% acetic acid, with gentle shaking in the
dark. After rinsing for 1 min in each of three changes of
distilled water, the slides were dried, dehydrated in
xylene and coverslipped with DPX. For stereological
study, every sixth section in the series throughout the
entire hippocampus was used (see below).
Stereology
Hippocampal volumes (V) were estimated according to a
formula based on the modified Cavalieri method: V =
Σa × tnom ×1 / s s f ,w h e r ea is area of the region of the
delineated subfield measured by AxioVision Rel. 4.8
software,, tnom is the nominal section thickness (of 30
μm in this study), and ssf is the fraction of the sections
sampled or section sampling fraction (of 1/6 in this
Table 1 Primary Antibodies used
Antigen Host Manufacturer Dilution used*
Calbindin D-28 K rabbit Cell signaling 1:200 (IF)
Glial fibrillary acidic protein mouse Millipore 1:5,000 (IF)
NeuN (a neuronal maker) mouse Millipore 1:1000 (IF)
NF-B p52-Ser865 rabbit Abcam 1:200 (IH)
NF-B p52-Ser869 rabbit Abcam 1:200 (IH)
NF-B p65-Ser276 rabbit Abcam 1:200 (IH)
NF-B p65-Ser311 rabbit Abcam 1:200 (IH)
NF-B p65-Ser468 rabbit Abcam 1:200 (IH)
NF-B p65-Ser529 rabbit Abcam 1:200 (IH)
TNF-a goat R&D system 1:500 (IH)
1:200 (IF)
TNFp55R rabbit Abcam 1:200 (IF)
TNFp75R Rabbit Abcam 1:200 (IF)
* IHC, immunohistochemistry; IF, immunofluorescence.
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objective lens. The volumes are reported as mm
3
[24,25]. The optical fractionator was used to estimate
cell numbers. The optical fractionator (a combination of
performing counting with the optical disector, with frac-
tionator sampling) is a stereological method based on a
properly designed systematic random sampling method
that by definition yields unbiased estimates of popula-
tion number. The sampling procedure is accomplished
by focusing through the depth of the tissue (the optical
disector height, h; of 15 μm in all cases for this study).
The number of each cell type (C) in each of the subre-
gions is estimated as: C = ΣQ
- × t/h × 1/asf × 1/ssf,
where Q
- is the number of cells actually counted in the
disectors that fall within the sectional profiles of the
s u b r e g i o ns e e no nt h es a m p l e ds e c t i o n s ,a n dA s fi st h e
area sampling fraction calculated as the area of the
counting frame of the dissector, a(frame) (50 × 50 μm
2
in this study) and the area associated with each x, y
movement, grid (x, y step) (250 × 250 μm
2 in this
study) {asf = [a(frame)/a(x, y step)]}. FJB-positive cells
were counted with a 40 × objective lens. All FJB-positive
cells were counted regardless the intensity of labeling.
Cell counts were performed by two different investiga-
tors who were blind to the classification of tissues [20].
Quantification of data
For quantification of immunohistochemical data, images
were captured using an AxioImage M2 microscope and
AxioVision Rel. 4.8 software (15 sections per each ani-
mal). Figures were mounted with Adobe PhotoShop v
8.0. Images were converted to gray and white images.
The range of intensity values was obtained from the
selected images using Adobe PhotoShop v. 8.0. Based on
the mean range of intensity values, each image was nor-
malized by adjusting the black and white range of the
image using Adobe PhotoShop v. 8.0. Manipulation of
the images was restricted to threshold and brightness
adjustments to the whole image [21-23]. After regions
were outlined, 10 areas/rat (500 μm
2/area) were selected
from the hippocampus and gray values were measured.
Intensity measurements were represented as the mean
number of a 256 gray scale (NIH Image 1.59 software
and AxioVision Rel. 4.8 software). Values for back-
ground staining were obtained from the corpus callo-
sum. Optical density values were then corrected by
subtracting the average values of background noise
obtained from 15 image inputs.
Statistical analysis
All data obtained from the quantitative measurements
and electrophysiological study were analyzed using
one-way ANOVA to determine statistical significance.
Bonferroni’s test was used for post-hoc comparisons.
A p-value below 0.05 was considered statistically sig-
nificant [21-23].
Results
Seizure threshold
The criterion for time of seizure onset is the time point
showing a paroxysmal depolarizing shift that is defined
as lasting > 3 s and consisting of a rhythmic discharge
of > 2 Hz and usually between 4 and 10 Hz. Saline-
treated animals showed the beginning of epileptiform
discharges 768 s after pilocarpine injection (i.p.). BzATP,
OxATP, sTNFp55R and BzATP+sTNFp55R-infused ani-
mals showed the beginning of SE up to 946, 743, 763
and 816 s after pilocarpine injection, respectively, and
maintenance of SE until 2 hr after SE. These findings
indicate that BzATP, OxATP, sTNFp55R or BzATP
+sTNFp55R-infusion did not affect pilocarpine-induced
SE in rats (Figure 1).
TNF-a expression
In non-SE-induced animals of saline-infused groups,
TNF-a immunoreactivity was weakly detected in CA1-3
pyramidal cells and dentate granule cells. In addition,
hilar neurons also showed TNF-a immunoreactivity
(Figure 2A). This localization pattern of TNF-a immu-
noreactivity in the hippocampus was consistent with
previous studies [26-29]. BzATP-, OxATP-or
sTNFp55R-infusion did not affect the localization pat-
tern of TNF-a immunoreactivity in the hippocampus
(data not shown). Two days after SE, TNF-a immunor-
eactivity was slightly increased (not statistically signifi-
cant) in the hippocampus of saline-infused animals, as
compared to non-SE-induced animals (Figures 2A-B). In
BzATP-infused animals, TNF-a immunoreactivity in
dentate granule cells was significantly increased 1.7-fold
as compared with that in saline-infused animals (p <
0.05; Figures 2A-C). In addition, TNF-a immunoreactiv-
ity was readily apparent in the mossy fibers (stratum
lucidum), while TNF-a immunoreactivity in CA1-3
Figure 1 Effects of BzATP, OxATP, sTNFp55R, and BzATP
+sTNFp55R infusions on the timing of pilocarpine (PILO)-
induced seizure onset. There are no differences in seizure latency
among the groups.
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and 2D). In OxATP-infused animals, TNF-a immunor-
eactivity in dentate granule cells was significantly
decreased to about 50% that in saline-infused animals
(p < 0.05; Figures 2A and 2C). In A-438079-or A-740003-
infused animals, alterations in TNF-a immunoreactivity in
dentate granule cells were similar to those in OxATP-
infused animals (data not shown). In sTNFp55R-and
BzATP+sTNFp55R-infused animals, the alterations
in TNF-a immunoreactivity were similar those observed in
saline-and BzATP-infused animals, respectively (Figures 2A
and 2C). One week after SE, TNF-a immunoreactivity in
the hippocampus recovered to the level of non-SE-induced
animals within every group (Figures 2C-D). TNF-a immu-
noreactivity was also detected in microglia 1-7 days after
SE (data not shown). However, there was no difference in
TNF-a immunoreactivity within microglial cells of each
group.
TNFp55R expression
In non-SE-induced animals of saline-infused groups,
TNFp55R immunoreactivity was observed mainly in
GFAP-positive astrocytes (Figure 3A). Similarly, BzATP-,
OxATP-, A-438079, A-740003 or sTNFp55R-infusion
did not affect the localization pattern of TNF-a immu-
noreactivity in the hippocampus of non-SE-induced ani-
mals (data not shown). As compared to non-SE-induced
animals (Figure 3B), TNFp55R immunoreactivity was
gradually reduced in astrocytes 1-7 days after SE (P <
0.05, Figures 3C-D). BzATP, OxATP, A-438079, A-
740003, sTNFp55R or BzATP+sTNFp55R infusion did
not affect changes in TNFp55R immunoreactivity in the
hippocampus following SE (data not shown).
TNFp75R expression
In non-SE-induced animals of saline-infused groups,
TNFp75R immunoreactivity was observed in neurons and
GFAP-positive astrocytes (Figures 4A-B). BzATP, OxATP,
A-438079, A-740003, sTNFp55R or BzATP+sTNFp55R
infusion did not affect changes in TNFp55R immunoreac-
tivity in the hippocampus (data not shown). Two to three
days after SE, TNFp75R immunoreactivity was increased,
exclusively in CA3 neurons, to 1.3-(2 days after SE) and
1.5-(3 days after SE, data not shown) fold in saline-infused
animals, as compared with that in non-SE-induced animals
(P < 0.05, Figures 4C-D). In BzATP-infused animals,
TNFp75R immunoreactivity was increased, only in CA3
neurons, 1.7-(2 days after SE) and 1.8-(3 days after SE, data
not shown) fold as compared with that in saline-infused
animals (P < 0.05, Figures 4C-D). OxATP, sTNFp55R or
BzATP+sTNFp55R infusions effectively prevented changes
in TNFp75R immunoreactivity in the CA3 region following
SE (Figures 4C-D). The effect of A-438079-or A-740003
infusion on TNFp75R immunoreactivity was similar to that
of OxATP infusion (data not shown). One week after SE,
TNFp75R immunoreactivity in the CA3 region recovered
to the levels of non-SE-induced animals within every group
(Figure 4D).
Neuronal damage
In our previous study [30] and in preliminary studies
here, neuronal damage was first detectable 3 days after
SE. Therefore, we applied FJB stains to 3-day post-SE
animals of each group. Few FJB positive neurons were
detected in the hippocampus of non-SE-induced animals
in any group (data not shown). In saline-infused ani-
mals, FJB-positive neurons were detected in CA1-3 pyr-
amidal cells and dentate hilus neurons (Figures 5A-C).
T h en u m b e ro fF J B - p o s i t i v en e u r o n si nd e n t a t eg y r u s ,
CA1 and CA3 regions was 18,215 ± 2,568, 236,145 ±
51,976 and 69,469 ± 4,367, respectively (Figures 5B-C).
For BzATP-infused animals, the number of FJB-positive
neurons in dentate gyrus, CA1 and CA3 regions was
19,138 ± 2,841, 214,843 ± 42,368 and 12,418 ± 5,714,
respectively (Figure 5A). Thus, BzATP infusion attenuated
SE-induced neuronal damage in the CA3 region (P < 0.05,
Figures 5B-C). In contrast, OxATP-, A-438079, A-740003,
sTNFp55R and BzATP+sTNFp55R infusion increased the
number of FJB-positive neurons in the CA3 region to
117,428 ± 6,468, 131,456 ± 5,196, 129,345 ± 7,138,
122,987 ± 3,568 and 86,468 ± 9,789, respectively (Figures
5B-C). However, OxATP-, sTNFp55R or BzATP
+sTNFp55R infusion could not exacerbate SE-induced
neuronal damages in dentate gyrus or the CA1 region, as
compared to BzATP-infusion (Figures 5B-C).
NF-B phosphorylation
It is well established that TNF-a is a major stimulus to
phosphorylation of NF-B. To confirm TNF-a-mediated
signaling following SE, we performed an immunohisto-
chemical study using six phospho-NF-B antibodies. As
compared to control animals, p52-Ser865, p52-Ser869,
p65-Ser468, and p65-Ser529 NF-B phosphorylations
were unaltered in nuclei of CA1 and CA3 pyramidal
cells, dentate granule cells, and hilar neurons 2 days
after SE (data not shown). However, both p65-Ser276
and p65-Ser311 phosphorylations were increased, only
in the CA3 region, following SE. In non-SE-induced ani-
mals of saline-infused groups, moderate p65-Ser276
immunoreactivity was observed in nuclei of CA3 neu-
rons (Figures 6A-B). p65-Ser311 immunoreactivity was
also weakly detected in nuclei of CA3 neurons (Figures
6A-B and 6C). BzATP-, OxATP-, A-438079, A-740003,
or sTNFp55R-infusion did not affect the localization
patterns of p65-Ser276 or p65-Ser311 immunoreactivity
in the hippocampus of non-SE-induced animals (data
not shown). Two days after SE, both p65-Ser276 and
p65-Ser311 immunoreactivities in CA3 neurons were
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Page 5 of 12Figure 2 Effects of BzATP, OxATP, sTNFp55R, and BzATP+sTNFp55R infusion on TNF-a expression following SE. (A) TNF-a expression in
dentate granule cells and the CA3 region 2 days after SE. Bar = 100 μm (panel 1). (B) TNF-a expression in mossy fibers in saline-and BzATP-
infused animals 2 days after SE. In BzATP-infused animals, TNF-a immunoreactivity is colocalized with CB, a marker for mossy fibers. Bar = 100
μm (panel 1). (C) Quantitative analysis of TNF-a immunoreactivity in dentate granule cells following SE (mean ± S.E.M). *Value is significantly
different from saline-infused animals, p < 0.05. (D) Quantitative analysis of TNF-a immunoreactivity in the CA3 region following SE (mean ± S.E.
M). *Value is significantly different from saline-infused animals, p < 0.05.
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Page 6 of 12Figure 3 Effect of SE on TNFp55R expression. (A) Astroglial expression of TNFp55R in control animal. Bar = 100 μm. (B) Distribution of
TNFp55R immunoreactivity in hippocampus of a non-SE-induced animal in the saline-infused group. Bar = 100 μm. (C) Distribution of TNFp55R
immunoreactivity in hippocampus of a 1-week post-SE animal in the saline-infused group. Bar = 100 μm. (D) Quantitative analysis of TNFp55R
immunoreactivity in hippocampus following SE (mean ± S.E.M). There are no differences in TNFp55R immunoreactivity in hippocampus among
the groups.
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Page 7 of 12enhanced to 1.5-and 1.8-fold in saline-infused animals,
respectively (Figures 6A-C). In BzATP-infused animals,
both p65-Ser276 and p65-Ser311 immunoreactivities in
CA3 neurons were increased 2.1-and 2.9-fold as compared
with that in non-SE-induced animals (Figures 6A-C).
OxATP-, A-438079, A-740003, sTNFp55R-or BzATP+
sTNFp55R infusions effectively prevented increases in p65-
Ser276 and p65-Ser311 immunoreactivities in CA3 neurons
following SE (Figures 6A-C). One week after SE, phospho-
NF-B immunoreactivities were decreased to non-SE-
induced animal levels (Figures 6B-C). Following SE, how-
ever, both p65-Ser276 and p65-Ser311 immunoreactivities
were unaltered in CA1 pyramidal cells (Figure 6D) as well
as dentate granule cells (Figure 6E). Furthermore, BzATP-,
Figure 4 Effects of BzATP, OxATP, sTNFp55R, and BzATP+sTNFp55R infusions on TNFp75R expression following SE. (A) Double
immunofluorescence for TNFp75R and GFAP in CA1 region of a non-SE-induced animal in the saline-infused group. Bar = 100 μm. (B) Double
immunofluorescence for TNFp75R and NeuN in CA3 region of a non-SE-induced animal in the saline-infused group. Bar = 100 μm. (C) TNFp75R
expression in the CA3 region 2 days after SE Bar = 100 μm (panel 1). (D) Quantitative analysis of TNFp75R immunoreactivity in the CA3 region
following SE (mean ± S.E.M). *Value is significantly different from saline-infused animals, p < 0.05.
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Page 8 of 12OxATP-, A-438079, A-740003, or sTNFp55R infusions did
not affect the localization pattern of p65-Ser276 immunor-
eactivity in these regions following SE (data not shown).
Discussion
It is well established that normal rat brain constitutive
expresses biologically active TNF-a as well as TNF-a
mRNA [31-33] and that TNF-a may be produced by
neurons themselves [33]. These previous studies reveal
that TNF-a may serve as a mediator of neurotransmitter
release in the CNS. The P2X7 receptor is identified as a
mediator in response to acute brain injury, since the
synthesis and membrane localization of P2X7 receptor
are rapidly up-regulated in response to various stimuli,
including SE [31,34-37]. The P2X7 receptor engages
diverse signal cascades, which include initiation of rapid
Figure 5 Effect of BzATP, OxATP, sTNFp55R, and BzATP+sTNFp55R infusions on SE-induced neuronal death. (A) Representative
photographs of FJB staining following SE. As compared to saline-infusion, BzATP infusion attenuates neuronal damage in the CA3 region
(arrows), while OxATP infusion worsens it (arrowheads). (B) SE-induced neuronal damages in dentate gyrus, and in the CA1 and CA3 regions 3
days after SE. Bar = 100 μm. (C) Quantitative analysis of neuronal damage in dentate gyrus, and in the CA1 and CA3 regions 3 days after SE
(mean ± S.E.M). BzATP infusion alleviates SE-induced neuronal damage only in the CA3 region. However, the other treatments increase SE-
induced neuronal damage. *Value is significantly different from saline-infused animals, p < 0.05.
Kim et al. Journal of Neuroinflammation 2011, 8:62
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Page 9 of 12Figure 6 Effect of BzATP, OxATP, sTNFp55R, and BzATP+sTNFp55R infusions on SE-induced NF-B phosphorylation. (A) p65-Ser276 and
p65-Ser311 phosphorylation in the CA3 region following SE. Bar = 100 μm. (B) Quantitative analysis of p65-Ser276 phosphorylation in CA3
region following SE (mean ± S.E.M). *Value is significantly different from saline-infused animals, p < 0.05. (C) Quantitative analysis of p65-Ser311
phosphorylation in CA3 region following SE (mean ± S.E.M). *Value is significantly different from saline-infused animals, p < 0.05. (D-E) p65-
Ser276 and p65-Ser311 phosphorylations in CA1 and in dentate granule cells following SE. As compared to non-SE animals, there is no
difference in p65-Ser276 or p65-Ser311 phosphorylations in these regions 2 days after SE. Bar = 100 μm.
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Page 10 of 12release and processing of proinflammatory cytokines
including TNF-a [34,36,38]. Similar to previous studies
[26-29], the present study shows that TNF-a immunor-
eactivity is readily apparent in hippocampal neurons as
well as dentate granule cells in non-SE-induced animals.
Interestingly, BzATP-infusion increased TNF-a immu-
noreactivity in dentate granule cells following SE, while
OxATP-infusion decreased it. These findings indicate
that P2X7 receptor-mediated regulation of TNF-a
expression may not be a consequence of distinct effects
of each drug on seizure activity. This is because BzATP-
, OxATP-, A-438079, A-740003, sTNFp55R-and BzATP
+sTNFp55R infusions did not affect pilocarpine-induced
SE in rats. Furthermore, these infusions could not affect
basal level of TNF-a immunoreactivity in the hippocam-
pus. Therefore, the present findings suggest that altera-
tions in SE-induced TNF-a immunoreactivity may be
mediated by P2X7 receptor function.
TNF-a clearly possesses the ability to simultaneously
activate both cell death and cell survival pathways, and
this balance ultimately determines whether TNF-a pro-
motes neurodegeneration or neuroprotection. Basically,
TNF-related signal transduction pathways include NF-
B binding activity for TNFp55R contributing to cell
death [9] and downstream signaling via the TNFp75R
involves activation of p38 mitogen-activated protein
kinase to promote neuronal survival [10]. In the present
study, BzATP-infusion caused a restricted increase in
TNF-a immunoreactivity within dentate granule cells
and their axons, and mossy fibers, following SE. BzATP-
infusion also enhanced TNFp75R expression in response
to TNF-a overexpression, only in CA3 neurons, which
synapse with mossy fibers. Furthermore, the present
study shows that BzATP infusion attenuates SE-induced
neuronal damage, only in the CA3 region, while
OxATP-, A-438079, A-740003, sTNFp55R and BzATP
+sTNFp55R infusions exacerbate neuronal damage as
compared to saline-infused animals. Therefore, our find-
ings suggest that TNF-a-mediated signaling may play a
neuroprotective role against SE.
It has been reported that p65-Ser276 and p65-Ser311
phosphorylations of NF-B induced by TNF-a enhance
their transactivation potentials and their interactions
with cAMP response element-binding (CREB)-binding
protein (CBP), which is also important for the survival
of neurons [39-44]. In the present study, BzATP-infu-
sion enhanced TNFp75R expression with intensification
of p65-Ser276 and p65-Ser311 immunoreactivities fol-
lowing SE. In addition, sTNFp55R pretreatment could
not prevent SE-induced neuronal damages, and BzATP
+sTNFp55R infusion did not show protective effect of
BzATP. These findings indicate that the activation of
TNFp75R may protect CA3 neurons from SE via p65-
Ser276 and p65-Ser311 NF-B phosphorylations.
Microglia are a major producer of TNF-a in brain
[45,46]. Hide et al. [26] reported that TNF-a release
from microglia is induced by BzATP. P2X7 receptor
expression is increased in the rat hippocampus following
pilocarpine-induced SE [30,47]. With respect to these
previous reports, it is likely that TNF-a released from
microglia may also play a neuroprotective role in the rat
hippocampus following SE. In the present study, how-
ever, there was no difference in TNF-a immunoreactiv-
ity between microglia of each group. Although the
present data could not provide biological mechanism of
this phenomenon, it may be considered that the dosages
of OxATP, A-438079 and A-740003 applied in the pre-
sent study are insufficient to inhibit TNF-a expression
in microglia due to full P2X7 receptor expression.
Further studies are needed to elucidate the effectiveness
of P2X7 receptor agonists and antagonists to alter TNF-
a expression in activated microglia.
In conclusion, the present study suggests that TNF-a
induction by P2X7 receptor activation may ameliorate
SE-induced CA3 neuronal damage via enhancement of
p65-Ser276 and p65-Ser311 phosphorylations of NF-B.
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